Probiotics protect mice from ovariectomy-induced cortical bone loss

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Ohlsson, Claes ^a   Engdahl, Cecilia ^a   Fak, Frida ^b   Andersson, Annica ^a   Windahl, Sara H ^a   Farman, Helen H ^a   Movérare Skrtic, Sofia ^a   Islander, Ulrika ^a   Sjögren, Klara ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; INTERLEUKIN 1BETA; OSTEOPROTEGERIN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERAL; CALCIUM EXCRETION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; LACTOBACILLUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE AND BONES; BONE MARROW; BONE RESORPTION; CYTOKINES; FEMALE; INFLAMMATION MEDIATORS; LACTOBACILLUS; MICE; MICE, INBRED C57BL; MINERALS; ORGAN SIZE; OSTEOPROTEGERIN; OVARIECTOMY; PROBIOTICS; RANK LIGAND; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84898612135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092368     Document Type: Article

References (43)

1. Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, et al. (2000) Longterm risk of osteoporotic fracture in Malmo. Osteoporos Int 11: 669-674.
2. Melton LJ, 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) Perspective. How many women have osteoporosis? J Bone Miner Res 7: 1005-1010.
3. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423: 337-342. (Pubitemid 40852708)
4. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, et al. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309. (Pubitemid 129516268)
5. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, et al. (2006) High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296: 1353-1355. (Pubitemid 44427419)
6. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G (2008) Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93: 1952-1958. (Pubitemid 351656543)
7. Schett G, Kiechl S, Weger S, Pederiva A, Mayr A, et al. (2006) High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 166: 2495-2501. (Pubitemid 44913235)
8. Eriksson AL, Moverare-Skrtic S, Ljunggren O, Karlsson M, Mellstrom D, et al. (2013) High sensitive CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: The MrOS Sweden study. J Bone Miner Res.
9. Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, et al. (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24: 323-334.
10. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, et al. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130: 811-823. (Pubitemid 47332572)
11. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22: 724-729. (Pubitemid 351339101)
12. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
13. Maynard CL, Elson CO, Hatton RD, Weaver CT (2012) Reciprocal interactions of the intestinal microbiota and immune system. Nature 489: 231-241.
14. Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
15. Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, et al. (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27: 1357-1367.
16. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621-626.
17. Williams S, Wakisaka A, Zeng QQ, Barnes J, Martin G, et al. (1996) Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone 19: 637-644. (Pubitemid 27035844)
18. Pytlik M, Folwarczna J, Janiec W (2004) Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia. Calcif Tissue Int 75: 225-230. (Pubitemid 39331651)
19. Bron PA, van Baarlen P, Kleerebezem M (2012) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10: 66-78.
20. Yan F, Polk DB (2011) Probiotics and immune health. Curr Opin Gastroenterol 27: 496-501.
21. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, et al. (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137: 838S-846S.
22. Thompson DD, Simmons HA, Pirie CM, Ke HZ (1995) FDA Guidelines and animal models for osteoporosis. Bone 17: 125S-133S.
23. Lavasani S, Dzhambazov B, Nouri M, Fak F, Buske S, et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 5: e9009.
24. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(2/2) mice. J Clin Invest 104: 895-901. (Pubitemid 29536339)
25. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107: 2159-2164.
26. Clowes JA, Riggs BL, Khosla S (2005) The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208: 207-227. (Pubitemid 41746395)
27. Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, et al. (2010) Intracortical remodelling and porosity in the distal radius and postmortem femurs of women: a cross-sectional study. Lancet 375: 1729-1736.
28. Holzer G, von Skrbensky G, Holzer LA, Pichl W (2009) Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res 24: 468-474.
29. Zheng HF, Tobias JH, Duncan E, Evans DM, Eriksson J, et al. (2012) WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet 8: e1002745.
30. Bansal N, Katz R, de Boer IH, Kestenbaum B, Siscovick DS, et al. (2013) Influence of Estrogen Therapy on Calcium, Phosphorus, and Other Regulatory Hormones in Postmenopausal Women: The MESA Study. J Clin Endocrinol Metab.
31. McKane WR, Khosla S, Burritt MF, Kao PC, Wilson DM, et al. (1995) Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause - a clinical research center study. J Clin Endocrinol Metab 80: 3458-3464.
32. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, et al. (1999) Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25: 255-259. (Pubitemid 29406050)
33. Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, et al. (2007) Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci U S A 104: 11394-11399. (Pubitemid 47175151)
34. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, et al. (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106: 1481-1488. (Pubitemid 32038586)
35. Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, et al. (2007) TNFinduced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A 104: 11742-11747. (Pubitemid 47175083)
36. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNFinduced osteoclastogenesis. J Clin Invest 115: 282-290.
37. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319. (Pubitemid 27199902)
38. Bouladoux N, Hall JA, Grainger JR, dos Santos LM, Kann MG, et al. (2012) Regulatory role of suppressive motifs from commensal DNA. Mucosal Immunol 5: 623-634.
39. Marie JC, Letterio JJ, Gavin M, Rudensky AY (2005) TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061-1067. (Pubitemid 40524674)
40. Kim YG, Lee CK, Nah SS, Mun SH, Yoo B, et al. (2007) Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 357: 1046-1052. (Pubitemid 46693677)
41. Zaiss MM, Axmann R, Zwerina J, Polzer K, Guckel E, et al. (2007) Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 56: 4104-4112. (Pubitemid 350262338)
42. Luo CY, Wang L, Sun C, Li DJ (2011) Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol 8: 50-58.
43. Buchwald ZS, Kiesel JR, Yang C, DiPaolo R, Novack DV, et al. (2013) Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice. Bone 56: 163-173.